# OLANZAPINE
> **ANDA204319** · Abbreviated New Drug Application (Generic) · Sponsor: QILU · Approved 2016-01-27
## Drug
- **FDA Application Number:** ANDA204319
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OLANZAPINE
- **Generic name:** OLANZAPINE
- **Active ingredients:** OLANZAPINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** QILU
- **Manufacturer:** Upsher-Smith Laboratories, LLC
- **First approval:** 2016-01-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204319)
---
*AI Analytics · CC0 1.0*